Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal platelet rich plasma combined with oral tranexamic acid for facial melasma
TCTR20230317003Phase 3Completed
- Sponsor
- Walailak University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tranexamic acid in melasma, sponsored by Walailak University. Started Mar 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20230317003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230317003.